Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

China Building Nightmarish Surveillance State

A "Big-Brother-like" mass surveillance system is being developed…
Read more

EU Threatens to Block Export of Vaccines to UK

Ursula von der Leyen threatened to block the production of…
Read more

IAI Extends Air Defense Capabilities

Israel Aerospace Industries had finished multiple live firing…
Read more